Trials / Completed
CompletedNCT03284814
Bioavailability Study of CoQ10 Formulations in Healthy Elderly Adults
Single-dose and Multiple-dose Comparative Bioavailability Study of Three CoQ10 Formulations in Healthy Elderly Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Institute of Nutrition, Slovenia (Nutris) · Academic / Other
- Sex
- All
- Age
- 65 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
The single-center, randomized, open-label, three-period crossover bioavailability study will include 21 subjects who will test three CoQ10 formulations. Subjects will test 3 formulations of single dose CoQ10 within first 3 weeks to assess bioavailability, which will be followed with 2 weeks of continuous administration of one of study formulations to demonstrate and assesse multiple-dose profile of CoQ10.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Single dose intervention with Standard product (SP) | hard capsules, 100 mg |
| DIETARY_SUPPLEMENT | Single dose intervention with Comparative product (CP) | soft-gel capsules, 100 mg |
| DIETARY_SUPPLEMENT | Single dose intervention with Investigational product (IP) | syrup, 100 mg |
| DIETARY_SUPPLEMENT | Multiple dose intervention with Standard product (SP) | hard capsules, 100 mg - 14 days |
| DIETARY_SUPPLEMENT | Multiple dose intervention with Comparative product (CP) | soft-gel capsules, 100 mg - 14 days |
| DIETARY_SUPPLEMENT | Multiple dose intervention with Investigational product (IP) | syrup, 100 mg - 14 days |
Timeline
- Start date
- 2017-08-29
- Primary completion
- 2017-10-20
- Completion
- 2017-10-20
- First posted
- 2017-09-15
- Last updated
- 2019-03-20
Locations
3 sites across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03284814. Inclusion in this directory is not an endorsement.